Clinical trial
Antidepressant Effects on cAMP Specific Phosphodiesterase (PDE4) in Depressed…
NCT00369798 · National Institute of Mental Health (NIMH), NIH · Completed
Key facts
| NCT number | NCT00369798 |
|---|---|
| Title | Antidepressant Effects on cAMP Specific Phosphodiesterase (PDE4) in Depressed Patients |
| Official title | Antidepressant Effects on cAMP Specific Phosphodiesterase (PDE 4) in Depressed Patients |
| Lead sponsor | National Institute of Mental Health (NIMH), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Major Depressive Disorder, Healthy |
| Intervention type | Drug, Procedure |
| Interventions | PET scan, Rolipram |
| Enrollment | 100 |
| Start date | Aug 2, 2006 |
| Primary completion | Jun 16, 2016 |
| Completion | Oct 12, 2016 |
| First posted | Aug 29, 2006 |
| Last update posted | Jul 5, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: